A Study of M701 (EpCAM and CD3) in Malignant Ascites
Clinical trial NCT04501744 · COMPLETED
Trial details
- NCT number
- NCT04501744
- Sponsor
- Wuhan YZY Biopharma Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-30
- Primary completion
- 2022-02-28
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.